Roivant Sciences Ltd.
- ROIV
- NASDAQ
- Biotechnology
- Biopharmaceutical R&D
- Healthcare Technology
$33.53
Today −1.50%Quote Oct 16, 2026, 08:00 PM UTC
−16.13%over the last month
Max drawdown −16.6%From 1-month high −16.1%3 months −1.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$24.22B
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$47.71
+42.3% from here
Floor
$32.01
4.5% below price
Where the price sits
16 analysts
Analyst range, low to high
$41.00$55.00
- Price $33.53
- Resistance $33.73
- Consensus $47.71
The price is right under resistance. Analysts' average target sits about 42% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ROIVPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
721
Founded
2014